Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
0.08 USD
63.87 M USD
969.50 M USD
690.36 M
About GENOMMA LAB INTERNACIONAL SAB
Sector
CEO
Marco Sparvieri
Headquarters
Mexico City
Website
Founded
1996
ISIN
MX01LA010006
FIGI
BBG002QM6C69
Genomma Lab Internacional SAB de CV engages in the development, manufacturing and marketing of pharmaceutical, beauty and personal care products. The company was founded by Rodrigo Alonso Herrera Aspra on October 30, 1996 and is headquartered in Mexico City, Mexico.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of GNMLF is 1.27 USD — it has decreased by −0.39% in the past 24 hours. Watch Genomma Lab International SAB DE CV stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Genomma Lab International SAB DE CV stocks are traded under the ticker GNMLF.
We've gathered analysts' opinions on Genomma Lab International SAB DE CV future price: according to them, GNMLF price has a max estimate of 1.63 USD and a min estimate of 0.89 USD. Watch GNMLF chart and read a more detailed Genomma Lab International SAB DE CV stock forecast: see what analysts think of Genomma Lab International SAB DE CV and suggest that you do with its stocks.
GNMLF reached its all-time high on Dec 10, 2013 with the price of 2.94 USD, and its all-time low was 0.51 USD and was reached on Dec 19, 2018. View more price dynamics on GNMLF chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
GNMLF stock is 0.39% volatile and has beta coefficient of 0.81. Track Genomma Lab International SAB DE CV stock price on the chart and check out the list of the most volatile stocks — is Genomma Lab International SAB DE CV there?
Today Genomma Lab International SAB DE CV has the market capitalization of 1.38 B, it has decreased by −2.10% over the last week.
Yes, you can track Genomma Lab International SAB DE CV financials in yearly and quarterly reports right on TradingView.
Genomma Lab International SAB DE CV is going to release the next earnings report on Feb 19, 2025. Keep track of upcoming events with our Earnings Calendar.
GNMLF earnings for the last quarter are 0.03 USD per share, whereas the estimation was 0.03 USD resulting in a 22.22% surprise. The estimated earnings for the next quarter are 0.02 USD per share. See more details about Genomma Lab International SAB DE CV earnings.
Genomma Lab International SAB DE CV revenue for the last quarter amounts to 258.45 M USD, despite the estimated figure of 236.45 M USD. In the next quarter, revenue is expected to reach 195.96 M USD.
GNMLF net income for the last quarter is 33.50 M USD, while the quarter before that showed 34.44 M USD of net income which accounts for −2.72% change. Track more Genomma Lab International SAB DE CV financial stats to get the full picture.
Genomma Lab International SAB DE CV dividend yield was 5.57% in 2023, and payout ratio reached 69.55%. The year before the numbers were 3.41% and 41.31% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Dec 12, 2024, the company has 1.59 K employees. See our rating of the largest employees — is Genomma Lab International SAB DE CV on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Genomma Lab International SAB DE CV EBITDA is 203.24 M USD, and current EBITDA margin is 21.13%. See more stats in Genomma Lab International SAB DE CV financial statements.
Like other stocks, GNMLF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Genomma Lab International SAB DE CV stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Genomma Lab International SAB DE CV technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Genomma Lab International SAB DE CV stock shows the strong buy signal. See more of Genomma Lab International SAB DE CV technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.